Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: An analysis based on serial CT acquisition

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 5, 1998, Pages 1069-1077

  Waterman, Frank M ^a   Yue, Ning ^a   Corn, Benjamin W ^a   Dicker, Adam P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Brachytherapy; I 125; Pd 103; Post implant dosimetry; Prostate implants

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; CALCULATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; DRUG DISTRIBUTION; EDEMA; HISTOGRAM; HORMONAL THERAPY; HUMAN; IMPLANT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE;

BRACHYTHERAPY; EDEMA; HUMANS; IODINE RADIOISOTOPES; MALE; PALLADIUM; PROSTATE; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TIME FACTORS;

EID: 0032527941     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00152-7     Document Type: Article

References (11)

1. Roberson P.L., Narayana V., McShan D.L., Winfield R.J., McLaughlin P.W. Source placement error for permanent implant of the prostate. Med. Phys. 24:1997;251-261.
2. Yu Y., Waterman F.M., Suntharalingam N., Schulsinger A. Limitations of the minimum peripheral dose as a parameter for dose specification permanent I-125 prostate implants. Int. J. Radiat. Oncol. Biol. Phys. 34:1996;717-725.
3. Grimm P.D., Blasko J.C., Ragde H. Ultrasound-guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early stage prostate cancer; Technical concepts in planning, operative technique and evaluation. Atlas Urol. Clin. North Am. 2:1994;113-125.
4. Moerland M.A., Wijrdeman H.K., Beersma R., Bakker C.J.G., Battermann J.J. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;927-933.
5. Narayana V., Roberson P.L., Pu A.T., Sandler H., Winfield R.H., McLaughlin P.W. Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;1181-1185.
6. Waterman F.M., Yue N., Reisinger S., Dicker A., Corn B.W. Effect of edema on the post-implant dosimetry of an I-125 prostate implant A case study . Int. J. Radiat. Oncol. Biol. Phys. 38:1997;335-339.
7. Nath R., Anderson L.L., Luxton G., Weaver K.A., Williamson J.F., Meigooni A.S. Dosimetry of interstitial brachytherapy sources; recommedations of the AAPM Ratiation Therapy Committee Task Group 43. Med. Phys. 22:1995;209-234.
8. Wallner K., Roy J., Zelefsky M., Fuks Z., Harrison L. Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation. Int. J. Radiat. Oncol. Biol. Phys. 29:1994;863-867.
9. Roach M., Faillace-Akazawa P., Malfatti C., Holland J., Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Phys. 35:1996;1011-1018.
10. Hilaris B.S., Nori D., Anderson L.L. Atlas of brachytherapy. 1988;Macmillan, New York.
11. Prestidge B.R., Bice W.S., Kiefer E.J., Prete J.J. Timing of computed tomography-based post-implant assessment following permanent transperineal prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;1111-1115.